Alkermes plc - stock earnings

ALKS Upcoming estimated earnings

Date Actual / Estimated EPS Low Revenue Actual / Estimated Revenue High Revenue
May 1, 2024 AfterMarket 0.44 / 0.62 - 350.4 million / 369.9 million -

ALKS Quarterly earnings

DateEarningsRevenue
2023Q4 112.8 million USD 377.5 million USD
2023Q3 47.8 million USD 380.9 million USD
2023Q2 237.1 million USD 617.4 million USD
2023Q1 -41.8 million USD 287.6 million USD
2022Q4 -28.3 million USD 304.7 million USD
2022Q3 -64.0 million USD 252.4 million USD
2022Q2 -30.1 million USD 276.2 million USD
2022Q1 -35.9 million USD 278.5 million USD
2021Q4 873000 USD 324.5 million USD
2021Q3 -29.0 million USD 294.1 million USD
2021Q2 2.4 million USD 303.7 million USD
2021Q1 -22.4 million USD 251.4 million USD
2020Q4 -42.6 million USD 280.0 million USD
2020Q3 -134000 USD 265.0 million USD
2020Q2 -29.4 million USD 247.5 million USD
2020Q1 -38.7 million USD 246.2 million USD
2019Q4 -5.4 million USD 412.7 million USD
2019Q3 -52.9 million USD 255.2 million USD
2019Q2 -42.0 million USD 279.9 million USD
2019Q1 -96.4 million USD 223.1 million USD
2018Q4 -9.7 million USD 315.8 million USD
2018Q3 -34.4 million USD 248.7 million USD
2018Q2 -32.6 million USD 304.6 million USD
2018Q1 -62.5 million USD 225.2 million USD
2017Q4 -9.8 million USD 275.4 million USD
2017Q3 -36.3 million USD 217.4 million USD
2017Q2 -43.0 million USD 218.8 million USD
2017Q1 -68.9 million USD 191.8 million USD
2016Q4 -21.1 million USD 213.5 million USD
2016Q3 -62.7 million USD 180.2 million USD
2016Q2 -47.2 million USD 195.2 million USD
2016Q1 -77.4 million USD 156.8 million USD
2015Q4 -69.4 million USD 163.1 million USD
2015Q3 -81.0 million USD 152.7 million USD
2015Q2 -46.1 million USD 151.4 million USD
2015Q1 -30.7 million USD 161.2 million USD
2014Q4 30.5 million USD 175.2 million USD
2014Q3 -40.0 million USD 160.0 million USD
2014Q2 3.7 million USD 153.4 million USD
2014Q1 -24.4 million USD 130.2 million USD
2013Q4 18.1 million USD 154.5 million USD
2013Q3 -7.8 million USD 139.8 million USD
2013Q2 7.3 million USD 138.6 million USD
2013Q1 3.0 million USD 163.4 million USD
2012Q4 16.3 million USD 135.9 million USD
2012Q3 -16.7 million USD 124.0 million USD
2012Q2 22.4 million USD 152.2 million USD
2012Q1 -63.4 million USD 130.5 million USD
2011Q4 -14.8 million USD 125.6 million USD
2011Q3 -22.3 million USD 72.0 million USD
2011Q2 -13.2 million USD 61.9 million USD
2011Q1 -13.1 million USD 51.1 million USD
2010Q4 -11.4 million USD 44.0 million USD
2010Q3 -7.7 million USD 49.2 million USD
2010Q2 -13.4 million USD 42.3 million USD
2010Q1 -13.9 million USD 38.5 million USD
2009Q4 -6.8 million USD 44.2 million USD
2009Q3 -8.7 million USD 48.2 million USD
2009Q2 -10.2 million USD 47.5 million USD
2009Q1 -13.6 million USD 43.9 million USD
2008Q4 112.7 million USD 155.7 million USD
2008Q3 1.7 million USD 47.3 million USD
2008Q2 29.7 million USD 80.0 million USD
2008Q1 -18.3 million USD 62.4 million USD
2007Q4 168.9 million USD 50.8 million USD
2007Q3 7.7 million USD 58.6 million USD
2007Q2 8.7 million USD 68.9 million USD
2007Q1 3.5 million USD 64.8 million USD
2006Q4 2.9 million USD 62.4 million USD
2006Q3 3.7 million USD 61.2 million USD
2006Q2 -715000 USD 51.5 million USD
2006Q1 4.4 million USD 53.7 million USD
2005Q4 1.4 million USD 41.4 million USD
2005Q3 11.8 million USD 46.7 million USD
2005Q2 -13.7 million USD 24.8 million USD
2005Q1 -14.5 million USD 23.0 million USD
2004Q4 -9.0 million USD 23.6 million USD
2004Q3 -14.3 million USD 18.0 million USD
2004Q2 -36.1 million USD 11.5 million USD
2004Q1 -24.7 million USD 16.1 million USD
2003Q4 -20.9 million USD 11.2 million USD
2003Q3 -26.2 million USD 7.5 million USD
2003Q2 -30.6 million USD 4.3 million USD
2003Q1 -35.0 million USD 12.3 million USD
2002Q4 41.2 million USD 15.2 million USD
2002Q3 -67.8 million USD 9.5 million USD
2002Q2 -45.3 million USD 10.3 million USD
2002Q1 -22.5 million USD 12.6 million USD
2001Q4 -17.9 million USD 11.5 million USD
2001Q3 -12.6 million USD 14.5 million USD
2001Q2 -8.3 million USD 15.5 million USD
2001Q1 -11.0 million USD 9.9 million USD
2000Q4 -7.4 million USD 9.7 million USD
2000Q3 -8.3 million USD 7.5 million USD
2000Q2 9.8 million USD 29.0 million USD
2000Q1 -28.1 million USD -1.6 million USD
1999Q4 -17.2 million USD 9.5 million USD
1999Q3 -14.4 million USD 6.8 million USD
1999Q2 -8.3 million USD 8.2 million USD
1999Q1 -31.2 million USD 7.7 million USD
1998Q4 -2.2 million USD 13.6 million USD
1998Q3 -2.6 million USD 12.2 million USD
1998Q2 -5.1 million USD 10.3 million USD
1998Q1 -1.8 million USD 9.2 million USD
1997Q4 -3.0 million USD 7.8 million USD
1997Q3 -959554 USD 8.4 million USD
1997Q2 -4.0 million USD 5.9 million USD
1997Q1 -4.8 million USD 5.8 million USD
1996Q4 -4.2 million USD 5.5 million USD
1996Q3 -4.8 million USD 4.1 million USD
1996Q2 -4.9 million USD 4.4 million USD
1996Q1 -5.5 million USD 4.3 million USD
1995Q4 -2.8 million USD 3.1 million USD
1995Q3 -3.0 million USD 3.1 million USD
1995Q2 -2.5 million USD 3.5 million USD
1995Q1 -3.2 million USD 3.5 million USD
1994Q4 -1.9 million USD 3.6 million USD
1994Q3 -3.1 million USD 3.0 million USD
1994Q2 -3.7 million USD 2.3 million USD
1994Q1 -3.9 million USD 1.6 million USD
1993Q4 -5.0 million USD 1.3 million USD
1993Q3 -3.7 million USD 2.7 million USD
1993Q2 -4.7 million USD 2.3 million USD
1993Q1 -35.0 million USD 2.8 million USD
1992Q4 -2.1 million USD 2.7 million USD
1992Q3 -2.1 million USD 2.0 million USD
1992Q2 -900000 USD 2.1 million USD
1992Q1 ? USD 700000 USD
1991Q4 ? USD 700000 USD
1991Q3 -1.6 million USD 100000 USD
1991Q2 -1.9 million USD 100000 USD

ALKS Yearly earnings

DateEarningsRevenue
2023 355.8 million USD 1.7 billion USD
2022 -158.3 million USD 1.1 billion USD
2021 -48.2 million USD 1.2 billion USD
2020 -110.9 million USD 1.0 billion USD
2019 -196.6 million USD 1.2 billion USD
2018 -139.3 million USD 1.1 billion USD
2017 -157.9 million USD 903.4 million USD
2016 -208.4 million USD 745.7 million USD
2015 -227.2 million USD 628.3 million USD
2014 -30.1 million USD 618.8 million USD
2013 17.6 million USD 432.9 million USD
2012 25.0 million USD 575.5 million USD
2011 -113.7 million USD 390.0 million USD
2010 -45.5 million USD 186.6 million USD
2009 -39.6 million USD 178.3 million USD
2008 130.5 million USD 326.8 million USD
2007 167.0 million USD 240.7 million USD
2006 9.4 million USD 240.0 million USD
2005 3.8 million USD 166.6 million USD
2004 -73.9 million USD 76.1 million USD
2003 -102.4 million USD 39.1 million USD
2002 -106.9 million USD 47.3 million USD
2001 -61.4 million USD 54.1 million USD
2000 -16.9 million USD 56.0 million USD
1999 -68.0 million USD 22.9 million USD
1998 -41.1 million USD 43.7 million USD
1997 -9.8 million USD 31.3 million USD
1996 -18.8 million USD 19.8 million USD
1995 -13.7 million USD 14.0 million USD
1994 -11.9 million USD 12.3 million USD
1993 -17.3 million USD 7.8 million USD
1992 -40.1 million USD 9.5 million USD
1991 -8.1 million USD 1.7 million USD

ALKS

Price: $24.01

52 week price:
22.01
33.71

Payout Ratio Range:
-172.23%
-77.67%

Earnings Per Share: 3.06 USD

P/E Ratio: 22.03

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 283127

Ebitda: 39.2 million

Market Capitalization: 4.4 billion

Links: